Organogenesis

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$130,234
$109,976
$99,651
$108,531
Gross Profit
96,629
77,619
67,781
82,742
EBITDA
15,270
2,324
6,979
8,050
EBIT
8,909
-3,852
649
2,205
Net Income
-17,043
-2,100
-568
12,107
Net Change In Cash
130,234
109,976
99,651
108,531
Free Cash Flow
2,858
-12,384
7,289
10,756
Cash
90,477
89,346
104,338
98,226
Basic Shares
132,573
131,861
131,857
133,417

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$433,140
$450,893
$468,059
$338,298
Gross Profit
309,790
345,874
353,860
250,979
EBITDA
39,770
40,322
89,581
34,980
EBIT
16,321
22,291
72,905
26,797
Net Income
4,945
15,532
94,202
17,234
Net Change In Cash
433,140
450,893
468,059
338,298
Cost of Revenue
-11,238
29,722
24,436
Free Cash Flow
6,553
-9,039
30,758
-14,344
Cash
104,338
102,478
113,929
84,394
Basic Shares
132,746
132,383
133,662
111,360

Earnings Calls

Quarter EPS
2024-06-30
$0.04
2024-03-31
-$0.02
2023-12-31
-$0.004
2023-09-30
$0.02